LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 20 filers reported holding LOMBARD MED INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $399,000 | -73.9% | 3,473,452 | 0.0% | 0.29% | -72.7% |
| Q3 2017 | $1,528,000 | -15.4% | 3,473,452 | 0.0% | 1.06% | -26.4% |
| Q2 2017 | $1,806,000 | -33.3% | 3,473,452 | 0.0% | 1.44% | -28.8% |
| Q1 2017 | $2,709,000 | +33.3% | 3,473,452 | 0.0% | 2.02% | +18.8% |
| Q4 2016 | $2,032,000 | -36.5% | 3,473,452 | 0.0% | 1.70% | -44.6% |
| Q3 2016 | $3,201,000 | -15.5% | 3,473,452 | 0.0% | 3.07% | -22.6% |
| Q2 2016 | $3,786,000 | +0.9% | 3,473,452 | 0.0% | 3.96% | +13.7% |
| Q1 2016 | $3,751,000 | -15.6% | 3,473,452 | 0.0% | 3.48% | +29.9% |
| Q4 2015 | $4,446,000 | -63.9% | 3,473,452 | 0.0% | 2.68% | -62.7% |
| Q3 2015 | $12,331,000 | -18.4% | 3,473,452 | 0.0% | 7.20% | +5.0% |
| Q2 2015 | $15,110,000 | +14.5% | 3,473,452 | 0.0% | 6.86% | +22.2% |
| Q1 2015 | $13,199,000 | -40.2% | 3,473,452 | 0.0% | 5.61% | -10.4% |
| Q4 2014 | $22,056,000 | -14.0% | 3,473,452 | +3.6% | 6.26% | -59.1% |
| Q3 2014 | $25,647,000 | – | 3,352,544 | – | 15.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,473,452 | $3,751,000 | 3.48% |
| SV Health Investors, LLC | 1,077,499 | $1,131,000 | 0.84% |
| Aisling Capital LLC | 886,363 | $931,000 | 0.19% |
| Verition Fund Management LLC | 19,129 | $20,000 | 0.00% |
| Weiss Multi-Strategy Advisers LLC | 58,000 | $61,000 | 0.00% |
| Invesco Ltd. | 6,317,851 | $6,633,000 | 0.00% |
| Texas Yale Capital Corp. | 29,062 | $31,000 | 0.00% |
| Spark Investment Management LLC | 12,000 | $12,000 | 0.00% |
| HSBC HOLDINGS PLC | 18,236 | $19,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 31,618 | $33,000 | 0.00% |